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Summary 
Cohesin is the name of a multifunctional protein complex, which was initially discovered and characterized by its role in 
maintain cohered sister chromatids during chromosome segregation in cell division. However, in the last years a large 
number of studies and results have evidenced the implication of cohesin complexes in different crucial processes in cell 
life such as DNA replication, control of gene expression, heterochromatin formation, and DNA-repair. The canonical 
cohesin complex consists in four subunits named SMC1, SMC3 (Structural Maintenance of Chromosomes) and SCC1, 
SCC3 (Sister Chromatid Cohesion). Two last subunits have also denominated RAD21 for SCC1 and STAG for SCC3 in 
mammals. These four subunits, named also cohesin ind vidually, are able to form a ring-like structure (figure 1A), 
which could modulate different local chromatin confrmations depending on the interactions with diverse cohesin-
interacting proteins, which have been designated as cohesin cofactors and/or cohesin-regulators. 
Chromosomal instability is one of the hallmarks of cancer, generating chromosomic aberrations including a euploidy, 
loss of heterozygosity, chromosomal translocations etc. Mutations in genes encoding for proteins that control cell cycle 
are potential candidates in the generation of genom instability. Thus, cohesins and cohesin-regulators, which are key 
players in chromosome segregation and in DNA-damage repair, are obviously aspirant molecules for this research. 
 
Basic concepts of cohesins in 
chromosome segregation and DNA-
damage repair 
Chromosome miss-segregation and aneuploidy are 
frequently observed in most of cancer cells. Perhaps the 
two cellular mechanisms more critical for chromosomal 
stability in which cohesins are involved are 
chromosome segregation during cell division and 
DNA-damage repair, therefore, in this paper, I will 
center on the cohesins and cohesin-interacting proteins 
involved in these two cellular important processes and
their links with tumor formation and development. 
Although the multiple roles of cohesins remodeling 
chromatin structure have been extensively and detailed 
revised in the last time (for two example reviews see 
Barbero, 2009 and Nasmyth and Haering, 2009), 
following, I describe here briefly the most relevant 
concepts of cohesin dynamic in order to understand 
their potential involvement in tumorigenesis. 
Cohesin complexes preserve sister chromatid cohesion 
during cell division in mitosis and meiosis by bindi g 
along the arm and centromeres of chromosomes. For 
this function, cohesin needs to the action of other 
proteins; among the best characterized of these 
cofactors are the followings: the adherin complex 
formed by SCC2 and SCC4 proteins is required for the 
loading of cohesin complexes to chromosomes; the 
cohesion establishment/maintenance proteins Eco1 
acetyltransferase in yeast and the mammalian 
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homologues ESCO1 and ESCO2, which, by acetylation 
of the SMC3 subunit of cohesin complex, stabilizes the 
binding of cohesin to chromatin; PDS5A and B 
(Precocious Dissociation of Sister), WAPL (Wings 
Apart-L ike) and SORORIN are proteins involved in 
the maintenance of cohesion through their interaction 
with cohesin complex subunits and/or with other 
cohesin-regulators (figures 1B and 2A); Shugoshin 
("the guardian of the spirit" in Japanese) protein family 
SGO1 and SGO2, which are essentially implicated in 
the protection of sister chromatid cohesion at the 
centromeric regions and, finally, the cohesion removal 
proteins PLK1 (Polo L ike K inase 1), Aurora B and 
securin/separase complex (figure 2A). The two first 
molecules are protein-kinases that phosphorylate 
cohesin, essentially STAG subunit, triggering the 
removal of arm cohesins. Separase is a specific 
protease, which is inhibited by its cofactor securin; 
activation of the anaphase promoting 
complex/cyclosome (APC/C) leads to ubiquitination 
and degradation of securin, allowing cleavage of 
SCC1/RAD21 from centromeric cohesin complexes by 
separase and triggering the onset of anaphase. 
 
Figure 1. Cohesin complex and cohesin-regulators. A. Ring model of cohesin complex formed by four subunits SMC1, SMC3, 
RAD21/SCC1 and STAG/SCC3. Subunits SMC1, SMC3 and RAD21 conform the ring-like structure. STAG protein interacts with RAD21 
to complete the cohesin complex. B. Examples of cohesin-regulators. PDS5 and WAPL form a protein complex, which is associated to 
the cohesin complex by STAG interaction. Sororin is other cohesin-regulator that is also involved in the control of cohesin ring dynamic. 
 
 
Figure 2. Scheme of cohesin metabolism during chromosome segregation and DNA-damage repair. A. Dynamic of cohesin 
complex in chromosome segregation indicating the characterized cohesin-regulators involved in cohesin loading to chromosomes, sister 
chromatid cohesion establishment and maintenance, and cohesion dissolution during cell division. B. Involvement of cohesin complexes 
during DNA-damage repair. Cohesin are recruited to double strand break (DSB) areas to facilitate the repair process. Some cohesin-
regulators, such us Scc2/Scc4 loading complex and Eco1 cohesion establishment factor are also required for new cohesin loading in 
these chromosome damaged regions. See text for more details. 






Atlas Genet Cytogenet Oncol Haematol. 2012; 16(2)  159 
All these cohesin-regulators were firstly characterized 
studying its function in sister chromatid cohesion, but 
shortly after has been found evidence of its 
involvement in DNA repair and other cohesin tasks. 
The initial result on the participation of cohesins i  
theses mechanisms was already reported before 
cohesins were known to mediate sister chromatid 
cohesion; the Scc1 ortholog from Schizosaccharomyces 
pombe was first identified as a protein whose mutation 
causes sensitivity to radiation because damaged DNA 
cannot be properly repaired and, thus, called Rad21 
(Radiation-sensitivity) (Birkenbihl and Subramani, 
1992). Following experiments, essentially in budding 
yeast, showed that cohesin mutants are defective in 
repair damaged DNA and provided evidence that DNA 
repair depends on the function of cohesin to mediat 
sister chromatid cohesion. In addition, studies of 
Rad21-depleted chicken cells have shown that 
vertebrate cohesin also functions in both segregation 
and repair (Sonoda et al., 2001). This cohesin 
requirement could be explained because DNA double 
strand breaks (DSB) are preferentially repaired by 
recombination between sister chromatids and the 
cohesion between them would facilitate this process. In 
this sense, cohesin complexes are recruited to sites of 
DSB to contribute to DNA repair of these damaged 
regions of chromosomes (figure 2B). This cohesin 
recruitment also required: from Eco1/ESCO 
acetyltransferase (Heidinger-Pauli et al., 2009) and 
from a functional SCC2/SCC4 adherin complex (Ström 
et al., 2004). In addition to machinery of chromosome 
cohesion, another specific DNA-damage repair proteins 
are necessary for the cohesin localization to DSB sites 
(figure 2B). A component of the DNA-damage sensing 
complex MRX (Mre11/Rad50/Xsr2) is required for 
cohesin assembly around the DSB. Phosphorylation of 
histone H2AX by Mec1/Tel1 generates what is known 
as gH2AX. Yeast strains expressing a non-
phosphorylatable H2AX fail to recruit cohesin, thus 
suggesting that gH2AX may act as a signal for cohesin 
assembly (Unal et al., 2004). Interestingly, some 
modifications by phosphorylation of SMC1 and SMC3 
cohesin subunits are carried out by specific kinases 
following IR and UV damage. Mutations in SMC1 or 
SMC3 that prevent phosphorylation result in abrogated 
DNA-damage responses (Kitagawa et al., 2004). 
Although, currently the participation of other 
chromosome cohesion cohesin-regulators in DNA 
repair is poorly understood, probably future research 
will incorporate also some of these molecules to control 






segregation, DNA-damage repair 
and cancer  
Obviously, the multiple roles of cohesins (figure 3) 
make it difficult to determine how their lack of function 
contributes to the generation and development of 
tumors and probably in many cases, were involved 
several processes. In this review, I focus on the two 
functions of cohesins most clearly related to genome 
stability, chromosome segregation and DNA-damage 
repair, and on the currently available data and results 
linking mutations on cohesin and cohesin-regulators 
genes and tumorogenesis. 
 
Figure 3. Cohesin functions. Scheme of the main cell life 
processes in which cohesins have been functionally 
characterized. The two cohesin tasks in red are the principal 
focus of this review. 
Cohesin complex subunits  
RAD21 cohesin subunit has long been linked with 
cancer chemotherapy; inhibition of RAD21 expression 
by RNA interference in human breast cancer cells 
enhanced the cytotoxicity of etoposide and bleomycin 
in these cells (Atienza et al., 2005). In agreement with 
this result, Xu et al. (2011) reported that overexpssion 
of RAD21 gives resistance to chemotherapy in high-
grade luminal, basal and HER2 breast cancers. Mice 
lacking Rad21 gene function present early embryonal 
lethality, but heterozygous Rad21+/- animals were 
obtained by breeding. Rad21+/- mice were viable and 
developed to apparently normal adulthood without 
morphological defects. However, Rad21+/- mice have 
enhanced sensitivity to whole body irradiation, 
indicating that Rad21 gene dosage is critical for 
ionizing radiation (IR) response (Xu et al., 2010). 
The study of 11 somatic mutations in 132 human 
colorectal cancers identified 6 of them mapping to 3 
cohesin, SMC1a, SMC3 and STAG3, genes and 4 to a 
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Chromosomal instability is a characteristic of colorectal 
cancer cells, resulting in chromosome gain or loss. It i  
possible to argue that abnormal cohesin pathway 
activity leads to chromosome missegregation and 
chromosome instability. This hypothesis is supported 
by the observation that colorectal cancer cells exhibit 
up to 100-fold higher rates of missegregation than 
normal cells. In addition, using a microcell mediated 
chromosome transfer and expression microarray 
analysis, Notaridou et al. (2011) identified the cohesin 
subunit STAG3 gene as one of the nine genes 
associated with functional suppression of 
tumorogenicity in ovarian cancer cell lines and as a 
candidate gene associated with risk and development of 
epithelial ovarian cancer. Kalejs et al. (2006) found 
aberrant expression of meiotic-specific genes, including 
the meiotic specific cohesin genes REC8 and STAG3 in 
a lymphoma cell model. 
The other two members of the STAG cohesin family 
(STAG1 and STAG2) have been also implicated in 
cancer. The most frequent cause of familial clear cell 
renal cell carcinoma (RCC) is von Hippel-Lindau 
disease and the VHL tumor suppressor gene (TSG) is 
inactivated in most sporadic clear cell RCC. To identify 
candidate genes for renal tumorigenesis, Foster et al. 
(2007) characterized a translocation, t(3;6)(q22;q16.1) 
associated with multicentric RCC without evidence of 
VHL target gene dysregulation. The gene encoding for 
the human cohesin subunit STAG1 map within close 
proximity to the breakpoints and thus it is a candidate 
gene involved in RCC. In array studies searching for 
genome alterations in a series of 167 malignant 
myeloid diseases, Rocquain et al. (2010) found 
recurrent deletions of RAD21 and STAG2 genes, 
suggesting that cohesin components are new players in 
leukemogenesis. 
Chromosomal translocations are also frequently found 
in different cancer cells. The results studying a novel 
non-TCR chromosome translocations t(3;11)(q25;p13) 
and t(X;11)(q25;p13) activating LMO2 by juxtaposition 
with MBNL1 and STAG2 are consistent with LMO2 
upregulation via capture of MBNL1 or STAG2 
regulatory elements effected by t(3;11) or t(X;11), 
respectively (Chen et al., 2011). With the aim to 
identify genomic alterations, associated with exposure 
to radiation, Hess et al. (2011) used array comparative 
genomic hybridization to analyze a main (n=52) and  
validation cohort (n=28) of PTC from patients aged 
<25 y at operation and matched for age at diagnosis and 
residency. Both cohorts consisted of patients exposed 
and not ex-posed to radioiodine fallout. The study 
showed association of a gain on chromosome 7 
(7q11.22-11.23), which correlates with the expression 
of STAG3L3, a STAG3-truncated loci previously 
characterized and reported in our laboratory (Pezzi t 
al., 2000). 
Very recently, Solomon et al. (2011) found harbor 
deletions or inactivating mutations of STAG2 in a 
diverse range of human tumor types including 
glioblastomas, Ewing's sarcomas, melanomas, 
lymphomas, medulloblastomas and colorectal 
carcinomas. Although it is has been thought that 
inactivation of genes that control chromosome 
segregation is involved in generation of aneuploidy in 
human cancers, however, until this work, only few 
examples of human tumors confirming this hypothesis 
had been reported. These authors compared the STAG2 
gene function as a "caretaker" tumor suppressor gene 
that when inactivated results in chromosomal 
instability. 
So far, we have shown different studies that link cancer 
development to disorders in the four core cohesin 
subunit genes, but there are also several experimental 
data linking cohesin-interacting proteins with 
tumorigenesis. 
Cohesin-regulators: cohesin 
loading, cohesion establishment 
and maintenance  
Because the essential function of adherin complex 
SCC2/SCC4 in loading cohesin complexes to 
chromosomes during chromosome segregation and in 
DNA-damage repair, it is logical to assume that its lack 
of function have an impact on genomic stability, 
however, until I know, there are not experimental 
results implicating mutation in SCC2 and/or SCC4 
genes in human tumors. 
The study of gene expression profiling is very usefl to 
molecularly classify primary tumors. In such a study in 
melanoma cells, upregulation of activators of cell 
cycle, including ESCO2 cohesion establishment gene, 
has been reported and implicated in melanoma 
progression Ryu et al. (2007). Loss of the p-arm of 
chromosome 8 is frequently observed in breast, 
prostate, and other types of cancers. In a study of 273 
genes expressed on p-arm of chromosome 8 (five breast 
and three prostate human cancers) downregulation of 
ESCO2 gene was observed (Yamamoto and 
Yamamoto, 2008). 
PDS5B expression is lost in many cancers and PDS5B 
mutations in germ line provoke birth defects. Based on 
these results, Denes et al. (2010) hypothesized that 
PDS5B plays a role in stem cell differentiation and i  
embryonic carcinoma. PDS5B knockdown disrupted 
Oct4, Nanog and SOX2 patterns, in addition to others 
stem cell differentiation mechanisms. Their results 
suggested that the link between the PDS5B-related 
birth defects that shows Cornelia de Lange syndrome 
(CdLS; OMIM: 122470, 300590, 610759) and cancer is 
a disrupted early stem cell differentiation program. On 
the other hand, PDS5A, the other PDS5 member, is 
overexpressed in high-grade gliomas, which are 
characterized by a high degree of genome instability 
and aneuploidy (Hagemann et al., 2011), linking again 
lost of chromosome cohesion with genomic instability. 
WAPL was also identified as an oncogene in uterine 
cervical cancer and it is induced by human 
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papillomavirus (HPV) E6 and E7 oncoproteins. WAPL 
overexpression induces apparition of multinucleated 
cells and increases the number of chromatid breaks in 
the cell, contributing to molecular mechanisms of 
tumor progression from HPV-infected cells to cervical 
carcinoma (Ohbayashi et al., 2007). Later, these 
authors reported that human WAPL gene encodes a 
large number of spliced variants and that the expression 
patterns of these variants could have diagnostic 
potential for cervical lesions (Oikawa et al., 2008). 
Sororin, also known as cell division cycle associated 5 
(CDCA5) protein, has been recently identified as an 
up-regulated gene in mostly lung cancers using a 
cDNA array containing 27648 genes or expressed 
sequence tags (Nguyen et al., 2010). Sororin is 
phosphorylated by extracellular signal-regulated kinase 
(ERK) at Ser79 and Ser209 in vivo. The suppression of 
sororin expression by siRNAs or the inhibition of the 
interaction between sororin and ERK inhibited the 
growth of lung cancer cells indicating a functional role 
of activation of CDCA5/sororin in lung cell cancer 
proliferation. 
To investigate the putative role of the centromere 
cohesion guardian shugoshin 1 (SGO1) in human 
colorectal cancer, Iwaizumi et al. (2009) performed 
SGO1 knockdown using shRNA expression vector. 
Human SGO1 knockdown cells proliferated slowly and 
presented marked of chromosomal instability (CIN) in 
the form of aneuploidy. Other characteristics of these 
transfected cells were increased centrosome 
amplification, the presence of binucleated cells, and 
mitotic catastrophes. The results of this study showed 
that SGO1 down-regulation leads CIN in human 
colorectal cancer cells and it could be a molecule 




The complex separase and its inhibitor securin are 
responsible for the total dissolution of sister chromatid 
cohesion in anaphase. Mammalian securin gene was 
originally identified in 1997 and characterized as 
pituitary tumor-transforming gene (Pttg1), which 
encodes the PTTG protein, from rat pituitary tumor 
cells (Pei and Melmed, 1997). PTTG/securin is highly 
expressed in various tumors and it can induce human 
cellular transformation. PTTG/securin is associated 
with more aggressive tumor behavior and has been 
identified as one of 17 key signature genes associated 
with metastatic disease (Ramaswamy et al., 2003). In 
addition, a PTTG binding factor (PBF) was identified 
through its interaction with PTTG and it was 
characterized as a proto-oncogene that is upregulated in 
several cancers (Smith et al., 2010). PTTG1/securin is 
also overexpressed in hepatocellular carcinoma. 
Chronic infection with hepatitis B virus (HBV) is the 
main causal factor for hepatocellular carcinoma and the 
viral protein HBx plays an essential role in the 
pathogenesis of hepatic tumors. To investigate the 
putative correlation between the abnormal expression 
of PTTG1 and the tumorigenic mechanism of HBx, 
Molina-Jiménez et al. (2010) analyzed the PTTG1 
expression in biopsies from patients chronically 
infected with HBV in different disease stages and from 
HBx transgenic mouse model. These authors found that 
HBx viral protein promotes an accumulation of PTTG1 
by inhibition of PTTG1 ubiquitination and degradation. 
The molecular mechanism/s by which HBx carried out 
this inhibition is currently under research. 
Separase is the endopeptidase that cleaves RAD21 
cohesin subunit during to metaphase/anaphase 
transition causing the removal of cohesins and the 
separation of sister chromatids. Overexpression of 
separase induces premature separation of chromatids, 
lagging chromosomes, and anaphase bridges. In a 
mouse mammary transplant model, induction of 
separase expression in the transplanted FSK3 cells for 
3-4 weeks results in the formation of aneuploid tumors 
in the mammary gland (Zhang et al., 2008). In a later 
report, Meyer et al. (2009) showed that separase is 
significantly overexpressed in osteosarcoma, breast, 
and prostate tumor specimens. There is a strong 
correlation of tumor status with the localization of 
separase into the nucleus throughout all stages of the 
cell cycle. In addition, overexpression of separase 
transcript strongly correlates with high incidence of 
relapse, metastasis, and lower 5-year overall survival 
rate in breast and prostate cancer patients, suggestin  
that separase is an oncogene. 
Polo-like kinase 1 (PLK1) and Aurora B are two 
protein-kinases that have as substrates cohesins and 
other proteins involved in chromosome segregation. 
PlK1 is overexpressed in various human cancers, and 
this is mostly associated with poor prognosis 
(Strebhardt and Ullrich, 2006). The first data to 
associate PLK1 with neoplastic growth were generated 
by studies showing that PLK1 concentrations are also
increased in primary cancer tissues (Holtrich et al.,
1994). This prompted a number of studies that 
subsequently demonstrated that PLK1 is overexpressed 
in a broad spectrum of human tumors compared with 
normal controls. Furthermore, some reports have 
indicated that PLK1 expression is a reliable marker for 
identifying a high risk of metastasis (Dai et al., 2000). 
More recently, Ito el al. (2010) described the post-
transcriptional regulation of Plk1 expression by RNA 
interference mediates by miR-593* and Plk1 
downregulation in EC cells decreases cell proliferation 
in vitro via G2/M cell cycle arrest, and drastically 
suppresses tumor formation in vivo. 
Aurora B kinase is involved in different key functions 
during chromosome segregation to preserve genomic 
stability. Examples of these functions are: sister 
chromatid cohesion, chromosome condensation, mitotic 
spindle assembly, syntelic chromosome attachments 
and spindle assembly checkpoint (for a review see 
Vader and Lens, 2008). Aurora B is overexpressed in 
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cancer cells, and an increased level of Aurora B 
correlates with advanced stages of colorectal cancer. 
Overexpression of Aurora B results in multi-nucleation 
and polyploidy in human cells (Tatsuka et al., 1998) 
and, additionally, it has been reported that Aurora B 
overexpression induces chromosomes lagging in 
metaphase, chromosome segregation error, and errors 
in cytokinesis, and thus suggesting a direct link 
between Aurora B and carcinogenesis (Ota et al., 
2002). These findings and the crucial roles of Aurora B 
and PLK1 in chromosome dynamics during cell cycle 
have led to consider these two kinases as important 
targets for cancer therapy (de Cárcer et al., 2007; 
Strebhardt, 2010; Libertini et al., 2010). 
Concluding remarks 
Cohesin complex, initially characterized as a ring 
protein complex that maintains sister chromatids 
together during chromosome segregation, is now 
considered a real architect of chromatin structure 
during essential dynamic DNA processes. In many 
cases, these processes are designed to safeguard the 
stability of genetic material and its proper distribut on 
to the daughter cells. Thus, it is not surprising that 
when there are errors/problems in the cohesin complex 
metabolism related with this guardian function, one f 
the likely results was the formation of a tumor. 
Although this review focuses essentially on the role f 
cohesins in chromosome segregation and DNA-damage 
repair and their connection with tumorigenesis, other 
functions of cohesins are also possibly related with the 
development of human tumors. In this sense, recently 
Baysal et al. 2011, described that germ line mutations 
in SDHD, a mitochondrial complex II (succinate 
dehydrogenase) subunit gene at chromosome band 
11q23, cause highly penetrant paraganglioma tumors 
when transmitted through fathers. In contrast, matern l 
transmission rarely, if ever, leads to tumor 
development. They observed that hypermethylated 
adrenal tissues show increased binding of the 
chromatin-looping factor cohesin relative to the 
hypomethylated tissues, suggesting that this differential 
allelic interaction may result in maternal 
downregulation of SDHD and the parent-of-origin 
dependent tumor susceptibility. 
In recent years, an increasing number of scientific 
works showed that cohesin functions are mediated by 
the action of other proteins. These molecules can be 
subdivided into two kind of cohesin-interacting 
proteins: those that regulate different aspects of the 
cohesin metabolism and necessary for several functions 
(such as SCC2/SCC4, Eco1/ESCO) and those that 
contribute to one cohesin specific role by a spatial-
temporal interaction with cohesin complex (such as 
CCCTC-binding factor (CTCF) and MEDIATOR in the 
control of gene expression (Wendt et al., 2008; Kagey 
et al., 2010)). In addition, post-translational 
modifications, such as acetylation and phosphorylation, 
in specific residues of cohesin subunits are also 
required for specific cohesin functions, suggesting he 
putative existence of a cohesin code similarly to well 
established histone code. 
All these findings point to the initial denomination of 
cohesin is currently very limited and therefore some 
authors are beginning to use other terms, such us 
chromatin-looping factor (Baysal et al., 2011) or, from 
my point of view, more convenient chromosome 
architectins, which, by interaction with specific 
regulator proteins, model precise tridimensional 
structures at local regions of chromosomes to perform 
different and specific functions depending on the 
spatial-temporal requirements of cell life. The future 
research on the molecular mechanisms of both, the 
cohesin-interacting proteins and the specific cohesin 
post-translational modifications, and on the alterations 
in the cohesin network during pathological conditions 
is crucial in determining the relationships between this 
interesting ring protein complex and the 
formation/development of tumors in humans. 
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